Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yeming Wang

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 11, 2024
Procalcitonin-guided use of antibiotic in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized clinical trialWeili Sheng, Lixue Huang, Xiaoying Gu, et al.
Nature Communications|August 7, 2025
The efficacy and safety of inhaled peptide YKYY017 for COVID-19 patients with mild illness: a phase 2 randomized controlled trialYeming Wang, Lianhan Shang, Lei Wu, et al.
Chest|May 16, 2026
Anti-C5a antibody STSA-1002 for patients with acute respiratory distress syndrome due to viral pneumonia: a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trialYeming Wang, Xiaobo Huang, Zhenshun Cheng, et al.
Lancet (London, England)|March 15, 2020
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyFei Zhou, Ting Yu, Ronghui Du, et al.
Ebiomedicine|November 4, 2023
Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivorsXiaoying Gu, Siyuan Wang, Wanying Zhang, et al.
European Journal of Medical Research|August 25, 2025
Impact of prophylactic anticoagulation on hospitalized COVID-19 patients aged over 80 years: a multicenter prospective cohort studyFeiya Xu, Guohui Fan, Jing Han, et al.
The Lancet. Microbe|March 29, 2022
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort studyLi Guo, Geng Wang, Yeming Wang, et al.
Frontiers of Medicine|July 5, 2020
Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysisJiuyang Xu, Chaolin Huang, Guohui Fan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2020
Antibody Responses and Clinical Outcomes in Adults Hospitalized With Severe Coronavirus Disease 2019 (COVID-19): A Post hoc Analysis of LOTUS China TrialLili Ren, Guohui Fan, Wenjuan Wu, et al.
Emerging Microbes & Infections|March 18, 2021
Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective studyLi Guo, Yeming Wang, Liang Kang, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 11, 2024
Procalcitonin-guided use of antibiotic in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized clinical trialWeili Sheng, Lixue Huang, Xiaoying Gu, et al.
Nature Communications|August 7, 2025
The efficacy and safety of inhaled peptide YKYY017 for COVID-19 patients with mild illness: a phase 2 randomized controlled trialYeming Wang, Lianhan Shang, Lei Wu, et al.
Chest|May 16, 2026
Anti-C5a antibody STSA-1002 for patients with acute respiratory distress syndrome due to viral pneumonia: a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trialYeming Wang, Xiaobo Huang, Zhenshun Cheng, et al.
Lancet (London, England)|March 15, 2020
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyFei Zhou, Ting Yu, Ronghui Du, et al.
Ebiomedicine|November 4, 2023
Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivorsXiaoying Gu, Siyuan Wang, Wanying Zhang, et al.
European Journal of Medical Research|August 25, 2025
Impact of prophylactic anticoagulation on hospitalized COVID-19 patients aged over 80 years: a multicenter prospective cohort studyFeiya Xu, Guohui Fan, Jing Han, et al.
The Lancet. Microbe|March 29, 2022
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort studyLi Guo, Geng Wang, Yeming Wang, et al.
Frontiers of Medicine|July 5, 2020
Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysisJiuyang Xu, Chaolin Huang, Guohui Fan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2020
Antibody Responses and Clinical Outcomes in Adults Hospitalized With Severe Coronavirus Disease 2019 (COVID-19): A Post hoc Analysis of LOTUS China TrialLili Ren, Guohui Fan, Wenjuan Wu, et al.
Emerging Microbes & Infections|March 18, 2021
Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective studyLi Guo, Yeming Wang, Liang Kang, et al.
Pageof 16